A professor of law at the Texas A&M University School of Law in Fort Worth, and served as a Fulbright Scholar in India and a Fulbright Specialist for the South Asia region.
AMA J Ethics. 2020 Feb 1;22(2):E102-111. doi: 10.1001/amajethics.2020.102.
Although low- and middle-income countries (LMICs) bear 75% of the cancer burden globally, their available resources to treat cancer constitute less than 5% of global health resources. This inequity makes it imperative to take appropriate measures to treat and prevent cancer in LMICs, which should include consideration of trade and patent policies. This article highlights some impediments to effective use of existing policies to promote access to treatment and prevention measures in LMICs and offers recommendations about next steps.
尽管中低收入国家（LMICs）承担了全球 75%的癌症负担，但它们用于治疗癌症的可用资源还不到全球卫生资源的 5%。这种不平等使得采取适当措施在 LMICs 中治疗和预防癌症变得至关重要，这应包括对贸易和专利政策的考虑。本文重点介绍了在 LMICs 中有效利用现有政策来促进治疗和预防措施的获取方面存在的一些障碍，并就下一步行动提出了建议。
